Allergan, Hi-Tech Settle IP Case Over Generic Combigan

Law360, New York (June 1, 2011, 5:25 PM EDT) -- A Texas federal judge approved a settlement Tuesday resolving Allergan Inc.'s patent suit over Hi-Tech Pharmacal Co. Inc.'s bid to market a generic version of Allergan's glaucoma treatment Combigan.

U.S. District Judge T. John Ward signed off on an order dismissing all claims in Allergan's suit against Hi-Tech in accordance with a May 20 settlement.

Allergan and Hi-Tech filed a stipulation for dismissal on May 25, saying that four Allergan patents related to Combigan were valid and were infringed by the generic product described in Hi-Tech's...
To view the full article, register now.